骨质疏松性椎体骨折保守治疗预后评分(OVF-CTPS):基于前瞻性队列研究的保守治疗预后工具开发与验证
基于201例急性骨质疏松性椎体骨折保守治疗患者的前瞻性队列,随访6个月,保守治疗失败率为29.9%。研究识别出6个独立预测因子并构建OVF-CTPS评分(范围0-13),AUC为0.918,最佳截断值6分时灵敏度91.3%、特异度84.0%。低风险组(评分<6)治疗成功率为96.3%,高风险组(评分≥6)成功率为32.3%。
要点
- OVF-CTPS评分范围0-13,包含6个独立预测因子,AUC=0.918。
- 最佳截断值6分时灵敏度91.3%、特异度84.0%。
- 低风险组(<6分)成功率96.3%,高风险组(≥6分)成功率32.3%。
核心结论
- OVF-CTPS是经过验证的预后工具,整合骨折形态、损伤严重程度和基于MRI的灌注标志物,能准确分层患者保守治疗失败风险,帮助识别适合保守治疗的低风险患者和可能受益于早期手术评估的高风险患者。
研究设计与样本
- 前瞻性队列研究(Level III),纳入201例接受保守治疗的急性骨质疏松性椎体骨折患者,随访6个月,基线评估包括人口学、疼痛、生活质量及多模态影像(X线、CT和MRI),主要结局为保守治疗失败。
主要发现
- 保守治疗失败率为29.9%。
- 识别出6个独立预测因子:Sugita「弓形」或「凹形」型、站立位椎体塌陷程度<80%、中柱/后壁损伤、T2WI「弥漫低」信号、STIR线状黑信号、椎基底孔受累。
- OVF-CTPS评分范围0-13,AUC=0.918。
- 最佳截断值6分时,灵敏度91.3%、特异度84.0%。
- 低风险组(评分<6)治疗成功率为96.3%,高风险组(评分≥6)成功率为32.3%。
关键数值与推荐
- OVF-CTPS评分范围0-13,包含6个预测因子,AUC=0.918。
- 最佳截断值6分,灵敏度91.3%、特异度84.0%。
- 低风险组(<6分)成功率96.3%,高风险组(≥6分)成功率32.3%。
临床怎么用
- 作者认为,OVF-CTPS可准确分层患者保守治疗失败风险,帮助临床医生识别适合保守治疗的低风险患者和可能受益于早期手术评估的高风险患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: A prospective cohort study (Level III). OBJECTIVE: To develop and validate a clinical scoring system (Osteoporotic Vertebral Fracture Conservative Treatment Prognosis Score, OVF-CTPS) for predicting the prognosis of conservative treatment in patients with osteoporotic vertebral fractures (OVFs), addressing clinical uncertainty in treatment selection. SUMMARY OF BACKGROUND DATA: OVFs face uncertainty in choosing conservative versus surgical management. Ten percent to 40% of patients have conservative treatment failure ( e.g. , nonunion, collapse). Existing classification systems lack prognostic value, highlighting the need for a practical predictive tool. METHODS: Two hundred one patients with acute OVFs undergoing conservative treatment were prospectively followed for 6 months. Baseline assessments included demographics, pain, quality of life measures, and multimodal imaging (X-ray, CT, and MRI). The primary outcome was conservative treatment failure. Independent predictors were identified using multivariate logistic regression and weighted to create the OVF-CTPS, which was validated using receiver operating characteristic (ROC) analysis. RESULTS: The conservative treatment failure rate was 29.9%. Six independent predictors were identified: Sugita "bow-shaped" or "concave" type, standing vertebral collapse degree <80%, middle column/posterior wall injury, T2WI "diffuse low" signal, STIR linear black signal, and basivertebral foramen involvement. The OVF-CTPS (range: 0-13) demonstrated excellent predictive performance (AUC=0.918). At an optimal cutoff score of 6, the sensitivity was 91.3% and the specificity was 84.0%. The low-risk group (score <6) had a 96.3% treatment success rate, while the high-risk group (score ≥6) had a success rate of 32.3. CONCLUSION: The OVF-CTPS is a validated prognostic tool that integrates fracture morphology, injury severity, and MRI-based perfusion markers. It accurately stratifies patients based on their risk of conservative treatment failure, enabling clinicians to identify low-risk patients suitable for conservative care and high-risk patients who may benefit from early surgical evaluation.
引用
- Ao J, Cai R, Xu Z, et al. The Osteoporotic Vertebral Fracture Conservative Treatment Prognosis Score (OVF-CTPS): Development and Validation of a Prognostic Tool for Conservative Treatment of OVFs Based on a Prospective Cohort Study. Spine (Phila Pa 1976). 2026. PMID: 41543135. doi:10.1097/BRS.0000000000005622
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。